Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients?

摘要: In renal transplant recipients, hypertension is common and associated with increased cardiovascular allograft rejection risks. Ambulatory blood pressure monitoring required for its accurate diagnosis adequate treatment, as it clearly offers several advantages over office or casual measurements. First, correlates better target-organ damage mortality. Second, ambulatory can eliminate "white coat" hypertension. Most important the identification of nocturnal hypertension, an independent risk factor. A circadian nondipping pattern often found in most probably resulting from cyclosporine persistent fluid overload early posttransplant phase (approximately 70% prevalence), but reflecting underlying (parenchymal vascular) disease when 25% prevalence) beyond first year posttransplant.